Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
VIROPHARMA INCORPORATED v. HAMBURG et al
Case Number:
1:12-cv-00584
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
January 09, 2013
ViroPharma Denied Block On Generic Vancocin Approval
A Washington federal judge on Wednesday ended ViroPharma Inc.'s bid to cancel the U.S. Food and Drug Administration's approval of generic versions of antibiotic Vancocin and extend its exclusive rights to the drug, saying the FDA had acted properly in approving the generics.
-
September 05, 2012
FDA Fights Back Against ViroPharma's Generic Vancocin Suit
ViroPharma Inc. doesn't deserve three more years of exclusive rights for its Vancocin, the U.S. Food and Drug Administration told a Washington federal judge Tuesday in a motion to dismiss a lawsuit over the agency's approval of generic versions of the antibiotic.
-
July 23, 2012
FDA Wrongly Approved Generic Vancocin, ViroPharma Argues
The U.S. Food and Drug Administration violated both the Federal Food, Drug and Cosmetic Act and its own regulations when it approved generic versions of the gastrointestinal antibiotic Vancocin, the drug's manufacturer, ViroPharma Inc., argued in a brief Friday.
-
April 24, 2012
ViroPharma Loses Bid To Block Generic Vancocin
ViroPharma Inc. lost a bid to temporarily block the U.S. Food and Drug Administration's recent approval of generic versions of the antibiotic Vancocin after a Washington federal judge ruled Monday that doing so would deprive the public of low-cost alternatives to the drug.
-
April 19, 2012
Judge Balks At ViroPharma's Bid To Halt Vancocin Generics
ViroPharma Inc.'s bid to halt the U.S. Food and Drug Administration's recent approval of three generic versions of its gastrointestinal antibiotic Vancocin hit a possible snag Thursday when a Washington federal judge said even a temporary hold on the agency's decision also could cause significant harm to the generics makers.
-
April 13, 2012
ViroPharma Sues FDA To Block Generic Vancocin Release
ViroPharma Inc. sued the U.S. Food and Drug Administration in Washington federal court Friday in an effort to block approval of generic versions of the gastrointestinal antibiotic Vancocin, four days after the agency rejected the company's bid for further market exclusivity for the drug.